Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 5/20 | 0.46 |
| ▸ | CA1 | P00915 | 5/20 | 0.46 |
| ▸ | CA2 | P00918 | 5/20 | 0.46 |
| ▸ | CA9 | Q16790 | 5/20 | 0.46 |
| ▸ | TYMP | P19971 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HBB | P68871 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | CCR10 | P46092 | 2/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8897393 | 1.00 | KMT2A (0.47) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL8855488 | 1.00 | KMT2A (0.47) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL6960235 | 0.89 | TYMP (0.41) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL11390072 | 0.76 | CA12 (0.64) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL15597325 | 0.73 | TYMP (0.56) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL29579255 | 0.73 | CA12 (0.53) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL16752479 | 0.73 | CA12 (0.53) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL8530813 | 0.73 | LMNA (0.59) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL9272320 | 0.73 | KMT2A (0.54) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL10842757 | 0.72 | KMT2A (0.41) | KMT2ACA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281875-A1 | SUBSTITUTED EPOXIDE MODIFIED SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS | GLOBAL THERMOSTAT OPERATIONS LLC (US) | 2025-09-11 | — | — | US | claimed |
| EP-4519008-A2 | SUBSTITUTED EPOXIDE MODIFIED SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS | Global Thermostat Operations, LLC (US) | 2025-03-12 | — | — | EP | claimed |
| CN-119325409-A | Substituted epoxide modified adsorbents, systems including adsorbents, and methods of using adsorbents | 全球温控营运有限责任公司 | 2025-01-17 | — | — | CN | claimed |
| CN-117982431-A | Method for preparing nanoparticles for diagnosis and treatment and nanoparticles for diagnosis and treatment | 陕西中医药大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117883596-A | T of hypoxia response 1 -T 2 Switchable MRI contrast agent, preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2024-04-16 | — | — | CN | claimed |
| WO-2023215873-A2 | SUBSTITUTED EPOXIDE MODIFIED SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS | GLOBAL THERMOSTAT OPERATIONS, LLC. (US) | 2023-11-09 | — | — | WO | claimed |
| US-5342959-A | Process for preparing chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and related compounds | WARNER-LAMBERT COMPANY (US) | 1994-08-30 | — | — | US | claimed |
| WO-1994015922-A1 | NOVEL PROCESS FOR PREPARING CHIRAL [[(2-BROMOETHYL)AMINO]METHYL]-2-NITRO-1H-IMIDAZOL-1-ETHANOL AND RELATED COMPOUNDS | WARNER LAMBERT COMPANY (US) | 1994-07-21 | — | — | WO | claimed |
| US-20250281875-A1 | SUBSTITUTED EPOXIDE MODIFIED SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS | GLOBAL THERMOSTAT OPERATIONS LLC (US) | 2025-09-11 | — | — | US | disclosed |
| CN-119732930-A | PH and light dual-response nano diagnosis and treatment agent and preparation method and application thereof | 国家纳米科学中心 | 2025-04-01 | — | — | CN | disclosed |
| EP-4519008-A2 | SUBSTITUTED EPOXIDE MODIFIED SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS | Global Thermostat Operations, LLC (US) | 2025-03-12 | — | — | EP | disclosed |
| CN-119325409-A | Substituted epoxide modified adsorbents, systems including adsorbents, and methods of using adsorbents | 全球温控营运有限责任公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-117982431-A | Method for preparing nanoparticles for diagnosis and treatment and nanoparticles for diagnosis and treatment | 陕西中医药大学 | 2024-05-07 | — | — | CN | disclosed |
| CN-117883596-A | T of hypoxia response 1 -T 2 Switchable MRI contrast agent, preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2024-04-16 | — | — | CN | disclosed |
| US-4596817-A | Chemopotentiating agents | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1986-06-24 | — | — | US | disclosed |
| US-4581368-A | ANTICARCINOGENIC AGENT POTENTIATORS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1986-04-08 | — | — | US | disclosed |
| EP-0095906-A1 | Improvements relating to compounds useful in radiotherapy or chemotherapy | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1983-12-07 | — | — | EP | disclosed |
| EP-0000928-B1 | NITROIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS WELL AS THEIR PREPARATION | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-03-18 | — | — | EP | disclosed |
| US-4241060-A | FOR SENSITIZING HYPOXIC CELLS TO RADIATION; ANTIPROTOZAL AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1980-12-23 | — | — | US | disclosed |
| EP-0000928-A1 | Nitroimidazoles and pharmaceutical compositions containing them as well as their preparation | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-03-07 | — | — | EP | disclosed |